Comparing subcutaneous vs intravenous amivantamab with lazertinib in EGFR-mutated advanced NSCLC: Analysis of Asian patients from PALOMA-3

被引：0

作者：

Lee, S-H. ^{[1
]}

Akamatsu, H. ^{[2
]}

Yang, J. C-H. ^{[3
]}

Lim, S. M. ^{[4
]}

Liu, B. ^{[5
]}

John, T. ^{[6
]}

Wang, J. ^{[7
]}

Ohe, Y. ^{[8
]}

Kondo, M. ^{[9
]}

Tamiya, M. ^{[10
]}

Danchaivijitr, P. ^{[11
]}

Hsu, P-C. ^{[12
]}

Zhuo, J. ^{[13
]}

Saadoun, C. ^{[14
]}

Saxena, N. ^{[14
]}

Balaburski, G. ^{[15
]}

Ribeiro, L. ^{[16
]}

Gamil, M. ^{[15
]}

Baig, M. ^{[17
]}

Cheng, Y. ^{[18
]}

机构：

[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea

[2] Wakayama Med Univ, Internal Med 3, Wakayama, Japan

[3] Natl Taiwan Univ, Dept Med Oncol, Ctr Canc, Taipei, Taiwan

[4] Yonsei Univ, Coll Med, Dept Internal Med, Div Med Oncol, Seoul, South Korea

[5] Harbin Med Univ Canc Hosp, Dept Resp Med, Harbin, Peoples R China

[6] Univ Melbourne, Peter MacCallum Canc Ctr, Med Oncol, Melbourne, Vic, Australia

[7] Fudan Univ, Shanghai Canc Ctr, Med Oncol, Shanghai, Peoples R China

[8] Natl Canc Ctr, Thorac Oncol, Tokyo, Japan

[9] Fujita Hlth Univ, Sch Med, Dept Resp Med, Toyoake, Aichi, Japan

[10] OICI Osaka Int Canc Inst, Thorac Oncol Dept, Osaka, Japan

[11] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Med, Bangkok Noi Campus, Bangkok, Thailand

[12] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Thorac Med, Taoyuan, Taiwan

[13] Janssen China Res & Dev, Stat & Decis Sci, Beijing, Peoples R China

[14] Janssen Asia Pacific, Asia Pacific, Med Affairs, Singapore, Singapore

[15] Janssen Res & Dev, Johnson & Johnson Innovat Med, Spring House, PA USA

[16] Janssen Cilag Farmaceut, Janssen Res & Dev, Lisbon, Portugal

[17] Janssen Res & Dev, Clin Res & Dev, Raritan, NJ USA

[18] Jilin Canc Hosp, Thorac Oncol, Changchun, Jilin, Peoples R China

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.10.661

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

628MO

引用

页码：S1634 / S1634

页数：1